CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 

Cumulative Longeveron Inc 's Leverage Ratio for Trailing Twelve Months Period

LGVN's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

LGVN Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth 10.22 % 19.19 % - - -
Y / Y Total Liabilities Growth 33.18 % 23.12 % - - -
Leverage Ratio for Trailing Twelve Months Period 0.17 0.16 0.16 0.17 0.2
Total Ranking # 409 # 467 # 464 # 513 #
Seq. Equity Growth -16.22 % -14.36 % -8.4 % 67.7 % -9.4 %
Seq. Total Liabilities Growth -0.74 % 22.13 % 1.91 % 7.81 % -8.24 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite debt repayement of -0.74% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.17, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 148 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Longeveron Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 409, from total ranking in previous quarter at 467.

What is Leverage Ratio?
Who are LGVN's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 149
Sector # 239
S&P 500 # 408


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.18 0.17 0.17
(Sep 30 2022)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Kiora Pharmaceuticals inc   0.46 
Merus N v   0.46 
Calliditas Therapeutics Ab  0.45 
Ligand Pharmaceuticals Incorporated  0.44 
Chemocentryx Inc.  0.44 
Mereo Biopharma Group Plc  0.44 
Sonnet Biotherapeutics Holdings Inc.  0.44 
Beigene Ltd   0.43 
Atreca inc   0.43 
Macrogenics Inc   0.43 
Abvc Biopharma Inc   0.43 
Trevena inc   0.43 
Bioxcel Therapeutics Inc   0.43 
9 Meters Biopharma Inc   0.43 
Thorne Healthtech Inc   0.43 
Metacrine Inc   0.43 
Arcutis Biotherapeutics Inc   0.42 
Maia Biotechnology Inc   0.42 
Igm Biosciences Inc   0.42 
Scpharmaceuticals Inc   0.42 
Bicycle Therapeutics Plc  0.42 
Adial Pharmaceuticals Inc   0.41 
Entrada Therapeutics Inc   0.41 
Trevi Therapeutics Inc   0.41 
Verastem Inc   0.41 
Can fite Biopharma Ltd   0.40 
Roivant Sciences Ltd   0.39 
Clever Leaves Holdings Inc   0.39 
Biomarin Pharmaceutical Inc  0.39 
Opko Health Inc   0.38 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FOUNU's Profile

Stock Price

FOUNU's Financials

Business Description

Fundamentals

Charts & Quotes

FOUNU's News

Suppliers

FOUNU's Competitors

Customers & Markets

Economic Indicators

FOUNU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071